Merrithew & Thorsten’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,748
Closed -$370K – 35
2026
Q2
$370K Buy
1,748
+8
+0.5% +$1.57K 0.32% 21
2026
Q1
$341K Buy
1,740
+8
+0.5% +$1.55K 0.32% 21
2025
Q4
$300K Buy
+1,732
New +$315K 0.32% 21

Other funds holding DGX

Merrithew & Thorsten's DGX Position: Q3 2026 in Review

Merrithew & Thorsten sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 1,748 shares — an estimated $370K sold.

Merrithew & Thorsten first reported a position in DGX in Q4 2025 and held it in 3 quarters. The position peaked at $370K in Q2 2026. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Merrithew & Thorsten reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Merrithew & Thorsten sold 1,748 Quest Diagnostics shares in Q3 2026, an estimated $370K.
  • Merrithew & Thorsten first reported a position in Quest Diagnostics in Q4 2025 and held it in 3 quarters.
  • Merrithew & Thorsten's Quest Diagnostics position peaked at $370K in Q2 2026.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.